These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16219725)

  • 21. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration: results of an effectiveness study.
    Sharma S; Bakal J; Oliver-Fernandez A; Blair J
    Arch Ophthalmol; 2004 Jun; 122(6):853-6. PubMed ID: 15197060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported acute decrease in visual acuity after photodynamic therapy for age-related macular degeneration.
    Recchia FM; Greenbaum S; Recchia CA; Ruby AJ; Alldredge CD; Hassan TS
    Retina; 2006; 26(9):1042-8. PubMed ID: 17151492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.
    Lai TY; Chan WM; Lam DS
    Am J Ophthalmol; 2004 May; 137(5):826-33. PubMed ID: 15126146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.
    Augustin AJ; Puls S; Offermann I
    Retina; 2007 Feb; 27(2):133-40. PubMed ID: 17290193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
    Marticorena J; Gomez-Ulla F; Fernandez M; Pazos B; Rodriguez-Cid MJ; Sanchez-Salorio M
    Am J Ophthalmol; 2006 Aug; 142(2):335-7. PubMed ID: 16876524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration.
    Theodossiadis GP; Panagiotidis D; Georgalas IG; Moschos M; Theodossiadis PG
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):13-8. PubMed ID: 12545287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.
    Ruiz-Moreno JM; Montero JA; Barile S; Zarbin MA
    Retina; 2006; 26(6):602-12. PubMed ID: 16829800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration.
    Pawlak D; Glacet-Bernard A; Papp M; Roquet W; Coscas G; Soubrane G
    Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: one-year results.
    Gupta R; Browning AC; Wu K; Sokal M; Amoaku WM
    Am J Ophthalmol; 2005 Mar; 139(3):561-2. PubMed ID: 15767080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
    Wykrota H; Gierek-Łapińska A
    Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of subfoveal choroidal neovascularization secondary to age related macular degeneration with single treatment of verteporfin photodynamic therapy: a safety and short-term outcome.
    Tayanithi P; Pisankosakul P; Laksakapuk P
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S78-82. PubMed ID: 16083167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.